Remission Factors in Anorexia Nervosa
About the study
Anorexia Nervosa (AN) is a complex and multifactorial psychiatric disease that affects mostly women and is characterized by a self-restriction of food intake leading to life-threatening consequences whose underlying mechanisms are largely unexplored. AN encompasses a constellation of risk factors including genetic, biological, neuro-psychological and social factors. Although AN has a prevalence of only 1-3% in the general population, it has the highest mortality rate amongst any psychiatric disorder. Recovery of normal feeding behaviour in patients often requires several months with a large between-patient variability and a high percentage of relapse, which can occur in 35 to 41% of the patients. There is a huge unmet need for optimal understanding of processes underlying relapse. Reward processing abnormalities represents an important hypothesis underlying AN development and perpetuation. We aim to investigate the mechanisms that contribute to the maintenance and chronicity of the disease after inpatient treatment with a longitudinal design across intensive standardized inpatient treatment. We will challenge our hypothesis through brain imaging, neuropsychological, metabolic and genetic approaches. One hundred twenty-five AN female patients admitted for intensive inpatient treatment will be recruited and evaluated: at admission, after weight recovery and at 6 months after discharge with neurocognitive tests (including the Delay Discounting Task), genetic/epigenetic examination, hormonal blood samples (at each visit and repeated sampling around a meal for a 10-patient subgroup) and brain imaging (including fMRI during a Delay Discounting Task for fifty patients). One hundred healthy controls will be also recruited and be subjected to the same study procedures.
Who can take part
You may be eligible to participate in the study if you meet the following criteria:
INCLUSION CRITERIA
Inclusion Criteria:
- DMS 5 criteria for Anorexia Nervosa
- BMI < 18.5 kg/m²
- Being able to consent
- fluent in French
- Being affiliated to a social security scheme or being the beneficiary of such a scheme.
- Having signed the informed consent
EXCLUSION CRITERIA
Exclusion Criteria:
- Deprived of liberty subject (judicial or administrative decision)
- Refusal to participate
- Presenting an unstabilized serious physical illness or psychiatric disorder compromising the follow up according investigator evaluation
- Contraindication for IRMf
- Pregnant or breast-feeding women
Study Locations
Enter your ZIP code/Postal code/PIN code to locate study sites near you:
How to Apply
Contact the study center to learn if this study is a good match for you.
Study’s details
Contition
Anorexia Nervosa
Age (in years)
18 - 65
Participants needed
225
Est. Completion Date
Sep 30, 2025
Treatment type
Observational
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
ClinicalTrials.gov identifier
NCT04560517
Study number
C1839
Understanding Clinical Trials
Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?